TEVA PHARMS USA INC FDA Approval ANDA 214326

ANDA 214326

TEVA PHARMS USA INC

FDA Drug Application

Application #214326

Documents

Letter2021-05-07

Application Sponsors

ANDA 214326TEVA PHARMS USA INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL100MG0TIOPRONINTIOPRONIN

FDA Submissions

UNKNOWN; ORIG1AP2021-04-26STANDARD

Submissions Property Types

ORIG1Null7

TE Codes

001PrescriptionAB

CDER Filings

TEVA PHARMS USA INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 214326
            [companyName] => TEVA PHARMS USA INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"TIOPRONIN","activeIngredients":"TIOPRONIN","strength":"100MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"04\/26\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214326Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2021-04-26
        )

)

© 2021 FDA.report
This site is not affiliated with or endorsed by the FDA.